799 related articles for article (PubMed ID: 33168037)
1. Immunosenescence: a key player in cancer development.
Lian J; Yue Y; Yu W; Zhang Y
J Hematol Oncol; 2020 Nov; 13(1):151. PubMed ID: 33168037
[TBL] [Abstract][Full Text] [Related]
2. Immunosenescence and cancer: Opportunities and challenges.
Fu Z; Xu H; Yue L; Zheng W; Pan L; Gao F; Liu X
Medicine (Baltimore); 2023 Nov; 102(47):e36045. PubMed ID: 38013358
[TBL] [Abstract][Full Text] [Related]
3. The Evolving Role of CD8
Huff WX; Kwon JH; Henriquez M; Fetcko K; Dey M
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181772
[TBL] [Abstract][Full Text] [Related]
4. Immunosenescence: molecular mechanisms and diseases.
Liu Z; Liang Q; Ren Y; Guo C; Ge X; Wang L; Cheng Q; Luo P; Zhang Y; Han X
Signal Transduct Target Ther; 2023 May; 8(1):200. PubMed ID: 37179335
[TBL] [Abstract][Full Text] [Related]
5. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy.
Liu X; Hoft DF; Peng G
J Clin Invest; 2020 Mar; 130(3):1073-1083. PubMed ID: 32118585
[TBL] [Abstract][Full Text] [Related]
6. Methods for Characterization of Senescent Circulating and Tumor-Infiltrating T-Cells: An Overview from Multicolor Flow Cytometry to Single-Cell RNA Sequencing.
Franzin R; Stasi A; Castellano G; Gesualdo L
Methods Mol Biol; 2021; 2325():79-95. PubMed ID: 34053052
[TBL] [Abstract][Full Text] [Related]
7. Senescence markers: Predictive for response to checkpoint inhibitors.
Moreira A; Gross S; Kirchberger MC; Erdmann M; Schuler G; Heinzerling L
Int J Cancer; 2019 Mar; 144(5):1147-1150. PubMed ID: 30151962
[TBL] [Abstract][Full Text] [Related]
8. Immunosenescence and cancer.
Pawelec G
Biogerontology; 2017 Aug; 18(4):717-721. PubMed ID: 28220304
[TBL] [Abstract][Full Text] [Related]
9. Exhaustion and senescence: two crucial dysfunctional states of T cells in the tumor microenvironment.
Zhao Y; Shao Q; Peng G
Cell Mol Immunol; 2020 Jan; 17(1):27-35. PubMed ID: 31853000
[TBL] [Abstract][Full Text] [Related]
10. Considerations for successful cancer immunotherapy in aged hosts.
Hurez V; Padrón ÁS; Svatek RS; Curiel TJ
Clin Exp Immunol; 2017 Jan; 187(1):53-63. PubMed ID: 27690272
[TBL] [Abstract][Full Text] [Related]
11. Multiple myeloma causes clonal T-cell immunosenescence: identification of potential novel targets for promoting tumour immunity and implications for checkpoint blockade.
Suen H; Brown R; Yang S; Weatherburn C; Ho PJ; Woodland N; Nassif N; Barbaro P; Bryant C; Hart D; Gibson J; Joshua D
Leukemia; 2016 Aug; 30(8):1716-24. PubMed ID: 27102208
[TBL] [Abstract][Full Text] [Related]
12. Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity.
Legscha KJ; Antunes Ferreira E; Chamoun A; Lang A; Awwad MHS; Ton GNHQ; Galetzka D; Guezguez B; Hundemer M; Bourdon JC; Munder M; Theobald M; Echchannaoui H
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34112738
[TBL] [Abstract][Full Text] [Related]
13. T cell senescence: a new perspective on immunotherapy in lung cancer.
Huang M; Wang Y; Fang L; Liu C; Feng F; Liu L; Sun C
Front Immunol; 2024; 15():1338680. PubMed ID: 38415245
[TBL] [Abstract][Full Text] [Related]
14. Are skin senescence and immunosenescence linked within individuals?
Waaijer MEC; Goldeck D; Gunn DA; van Heemst D; Westendorp RGJ; Pawelec G; Maier AB
Aging Cell; 2019 Aug; 18(4):e12956. PubMed ID: 31062498
[TBL] [Abstract][Full Text] [Related]
15. Immunosenescence, inflammaging, and cancer immunotherapy efficacy.
Rodriguez JE; Naigeon M; Goldschmidt V; Roulleaux Dugage M; Seknazi L; Danlos FX; Champiat S; Marabelle A; Michot JM; Massard C; Besse B; Ferrara R; Chaput N; Baldini C
Expert Rev Anticancer Ther; 2022 Sep; 22(9):915-926. PubMed ID: 35815381
[TBL] [Abstract][Full Text] [Related]
16. Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency.
Salminen A; Kaarniranta K; Kauppinen A
Cell Mol Life Sci; 2019 May; 76(10):1901-1918. PubMed ID: 30788516
[TBL] [Abstract][Full Text] [Related]
17. Cancer Immunotherapy Targets Based on Understanding the T Cell-Inflamed Versus Non-T Cell-Inflamed Tumor Microenvironment.
Gajewski TF; Corrales L; Williams J; Horton B; Sivan A; Spranger S
Adv Exp Med Biol; 2017; 1036():19-31. PubMed ID: 29275462
[TBL] [Abstract][Full Text] [Related]
18. The diseased kidney: aging and senescent immunology.
Chi M; Tian Z; Ma K; Li Y; Wang L; Nasser MI; Liu C
Immun Ageing; 2022 Nov; 19(1):58. PubMed ID: 36384564
[TBL] [Abstract][Full Text] [Related]
19. Cellular senescence in lymphoid organs and immunosenescence.
Budamagunta V; Foster TC; Zhou D
Aging (Albany NY); 2021 Aug; 13(15):19920-19941. PubMed ID: 34382946
[TBL] [Abstract][Full Text] [Related]
20. Immunosenescence and Its Hallmarks: How to Oppose Aging Strategically? A Review of Potential Options for Therapeutic Intervention.
Aiello A; Farzaneh F; Candore G; Caruso C; Davinelli S; Gambino CM; Ligotti ME; Zareian N; Accardi G
Front Immunol; 2019; 10():2247. PubMed ID: 31608061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
